Nutex Health reported a second-quarter 2026 net income of $65.8 million, or $9.38 per diluted share, reversing a net loss of $17.7 million a year earlier. A favorable amendment to the company's agreement with HaloMD and a reduction in the CMS administrative fee for the federal Independent Dispute Resolution process cut contract services expenses by $52.3 million during the quarter. Hospital division visits increased 9.6% year over year to 49,962, while same-hospital visits rose 6.3%. Total revenue declined 13.6% to $210.8 million, which the company attributed to favorable early-stage IDR improvements realized in the first half of 2025. Nutex Health ended the quarter with $205.2 million in cash and $31.1 million in long-term debt, and expects to open three new hospitals later in 2026.
Nutex Health IncQ2 net income swung to $65.8M profit from a loss, driven by cost reductions and margin gains.
